T‑box 2 expression is a useful indicator of the response to neoadjuvant chemotherapy for patients with locally advanced uterine cervical squamous cell carcinoma
Author(s) -
Yuta Inoue,
Takeshi Fukuda,
Shigenori Nanno,
Yuichiro Awazu,
Masahiro Shimomura,
Hiroaki Matsubara,
M. Yamauchi,
Tomoyo Yasui,
Toshiyuki Sumi
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.13016
Subject(s) - medicine , cisplatin , cervical cancer , oncology , oncogene , chemotherapy , gene knockdown , chemoradiotherapy , cancer , immunohistochemistry , cancer research , cell cycle , apoptosis , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom